FOR RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE
YZF PeptideResearch supply
Back to catalog

Research product specification

CBL60

Cerebrolysin

For Research Use Only. Not for human or veterinary use.

Cerebrolysin is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 1 listed specification. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.

Listed purity
99%+
Availability
Available for inquiry
Select specification60mg x 10vials

COA available on request

COACOA available on request

Volume discounts are available for larger purchasing plans. Please contact us for a quotation.

Delivery includedUsually within 7 days after dispatch

Quality resolutionRefund or replacement when approved

24/7 contactWholesale assistance on WhatsApp

Product profile

About Cerebrolysin

Cerebrolysin is a neuropeptide preparation derived from porcine brain proteins through a standardized enzymatic breakdown process. It is essentially a mixture of low-molecular-weight peptides (approx. 25%) and free amino acids (approx. 75%), along with trace elements such as magnesium, potassium, and calcium. This unique composition allows it to readily cross the blood-brain barrier and act directly on the central nervous system. Developed in Austria in 1949, Cerebrolysin is currently approved for clinical use in 44 countries, primarily in Europe and Asia, but it is not approved by the U.S. Food and Drug Administration (FDA). Its primary mechanisms of action include mimicking the effects of endogenous neurotrophic factors (such as NTF3) and stimulating the synthesis of brain-derived neurotrophic factor (BDNF), thereby providing neuroprotective and neurorestorative effects.

Main functions

  • 1.Neurorepair and Neuroprotection: In models of traumatic brain injury (TBI) and ischemic stroke, Cerebrolysin has been shown to promote neuroplasticity, enhance neurogenesis, and reduce neuronal damage and apoptosis. A study in patients with moderate TBI demonstrated significantly greater improvement on the Coma Recovery Scale-Revised (CRS-R) compared to standard care alone.
  • 2.Improves Cognitive Function: Multiple randomized controlled trials in patients with Alzheimer's disease and vascular dementia have shown that Cerebrolysin significantly improves global function and cognitive ability compared to placebo. A 28-week study reported a -1.708 improvement in ADAS-cog scores in the Cerebrolysin group over placebo.
  • 3.Promotes Post-Stroke Recovery: Clinical studies suggest that Cerebrolysin administered in the acute phase of ischemic stroke may help improve motor function and overall prognosis. A large randomized double-blind trial (CODEC study) on post-stroke cognitive impairment has been completed to further evaluate its efficacy.
  • 4.Adjunctive Therapy in Psychiatry: Preliminary research indicates potential benefits of Cerebrolysin in alleviating side effects of antipsychotics and improving symptoms in depression and autism spectrum disorders.

Recommended audience

  • "Patients with cognitive disorders such as Alzheimer's disease and vascular dementia.
  • Individuals requiring neurorehabilitation following acute ischemic stroke or traumatic brain injury.
  • Individuals seeking to improve cognitive and motor dysfunctions caused by neurological diseases or injuries.
  • Adjunctive treatment in certain psychiatric conditions (e.g., depression, schizophrenia), primarily to reduce medication side effects or improve cognitive symptoms.
  • "
Order formatOne box accepted
QuotationConfirmed on WhatsApp
DeliveryShipping and duties included
DocumentationPublished COA or available on request

Research product specification

Product information

Cerebrolysin is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 1 listed specification. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.

Handling information

Storage guidance

Keep unopened lyophilized products protected from light and moisture; store at 2-8°C short term or -20°C long term. After reconstitution, refrigerate according to product documentation and minimize freeze-thaw cycles.

Customer-first resolution

Report quality concerns within 14 days of delivery

Contact us with the order number, batch details and available photos. Opened products are accepted for review. When a quality claim is approved, you may choose a full refund or replacement shipment.